Skip to main content
TipRanks
Go Ultimate75% OFF

Cawachi Limited (2664) AI Stock Analysis

0 Followers
JP:2664

Cawachi Limited

(TSE/TYO:2664)

Select Model
Rating:57Neutral
Price Target:JPY 4,218.00â–²(3.38% Upside)
Action:reiterated
Date:11/07/26

The overall score is constrained by weak financial performance, specifically declining profitability and stagnant revenue, which is the most significant factor. A high P/E ratio further pressures the valuation. Positive technical momentum and a solid balance sheet provide some support, but the core earnings weakness and expensive valuation keep the score in the lower half of the range.

Positive Factors
Conservative Balance SheetLow leverage gives Cawachi financial resilience and preserves flexibility to fund store operations, maintain investment, or withstand weaker trading conditions. Stable-to-growing equity further supports solvency, although returns on that capital remain moderate.
Negative Factors
Stagnant RevenueFlat-to-declining revenue signals limited recent top-line expansion and suggests that store productivity, customer demand, or market growth has not been sufficient to accelerate sales. Without renewed revenue growth, operating leverage and long-term earnings progression may remain constrained.

Cawachi Limited (2664) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%40%50%JP:2664+43.39%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 88.95B
Dividend Yield
3.68%
Average Volume (3M)
78.71K
Price to Earnings (P/E)
30.7
Beta (1Y)
0.22
Revenue Growth
-0.88%
EPS Growth
-35.26%
Country
Japan
Employees
2,750
Sector
General
Sector Strength
55
Industry
Medical - Pharmaceuticals

Cawachi Limited Business Overview & Revenue Model

Company Description

Cawachi Limited manages drugstores in Japan. It is involved in retail and insurance dispensing of medicines, medical-related products, health foods, childcare products, cosmetics, daily necessities, general foods, confectionery. The company was found...

How the Company Makes Money

Cawachi Limited primarily makes money by operating retail stores and generating sales revenue from products sold to consumers. Key revenue streams generally include (1) over-the-counter pharmaceuticals and health-related items, (2) health and beauty/...

Cawachi Limited Financial Statement Overview

Summary

Financial performance is mixed. The balance sheet is strong with low debt and growing equity (Score: 75), but the income statement shows stagnant revenue and declining profitability (Score: 35). Cash flow is adequate and covers net income well (Score: 55). The overall financial health is stable but pressured by weak earnings.

Income Statement

35Negative

Balance Sheet

75Positive

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue283.28B284.49B287.82B285.96B281.87B279.46B
Gross Profit65.08B65.26B66.66B65.80B64.05B63.15B
EBITDA11.22B11.20B11.36B11.49B10.90B12.16B
Net Income2.99B3.20B4.88B4.71B4.18B4.83B
Balance Sheet
Total Assets199.10B199.61B200.96B197.24B195.24B192.48B
Cash, Cash Equivalents and Short-Term Investments41.61B38.11B36.67B35.62B38.45B38.96B
Total Debt14.97B16.11B16.60B16.73B19.55B22.92B
Total Liabilities85.08B83.68B86.55B85.94B87.51B87.83B
Stockholders Equity114.01B115.93B114.41B111.30B107.72B104.65B
Cash Flow
Free Cash Flow4.59B4.66B3.40B1.02B4.11B2.37B
Operating Cash Flow5.37B8.87B7.48B6.40B9.82B6.87B
Investing Cash Flow-939.00M-5.16B-4.51B-5.29B-5.84B-4.54B
Financing Cash Flow-2.69B-2.27B-1.92B-3.94B-4.49B-4.61B

Cawachi Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price4080.00

Price Trends

50DMA3872.32Positive
100DMA3674.46Positive
200DMA3350.42Positive

Market Momentum

MACD62.95Positive
RSI54.93Neutral
STOCH39.62Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2664, the sentiment is Positive. The current price of 4080.00 is below the 20-day moving average (MA) of 4085.50, above the 50-day MA of 3872.32, and above the 200-day MA of 3350.42, indicating a neutral trend. The MACD of 62.95 indicates Positive momentum. The RSI at 54.93 is Neutral, neither overbought nor oversold. The STOCH value of 39.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2664.

Cawachi Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:2664 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3391JP:339181OutperformJPY 1.13T20.317.13%1.88%――
JP:7649JP:764969NeutralJPY 550.50B17.889.94%1.24%8.97%-29.54%
JP:9989JP:998969NeutralJPY 458.81B15.6511.04%3.36%3.99%-0.48%
JP:3549JP:354962NeutralJPY 485.06B26.29―0.29%12.54%15.87%
JP:3349JP:334960NeutralJPY 512.38B16.29―1.27%8.99%3.61%
JP:2664JP:266457NeutralJPY 91.07B30.65―3.68%-0.88%-35.26%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-20%0%20%40%JP:2664JP:9989JP:7649JP:3391JP:3349JP:3549Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:2664 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:2664Cawachi Limited4080.001215.4442.43%
JP:9989Sundrug Co 3924.00-187.45-4.56%
JP:7649Sugi Holdings Co 1416.50-292.70-17.12%
JP:3391TSURUHA Holdings 2500.00-202.22-7.48%
JP:3349COSMOS Pharmaceutical Corporation6437.00-929.03-12.61%
JP:3549KUSURI NO AOKI HOLDINGS CO.,LTD.5073.001236.3532.22%

Cawachi Limited Corporate Events

Cawachi trims full-year sales forecast but keeps profits on track

Oct 28, 2026

Cawachi Limited has revised its full-year earnings forecast for the fiscal year ending March 15, 2027, trimming projected net sales from 285 billion yen to 283 billion yen, while leaving operating profit, ordinary profit and profit attributable to ow...

Cawachi Limited Warns of Profit Decline Despite Stable Sales and Dividend Payouts

Oct 28, 2026

Cawachi Limited reported a modest 0.8% year-on-year decline in net sales to ¥144.1 billion for the first half of fiscal 2027, with operating profit down 6.2% and profit attributable to owners of parent falling 8.6%, leading to lower basic earnings pe...

Cawachi Nears Limit in ¥2 Billion Share Buyback Program

Sep 2, 2026

Cawachi Limited has completed a board-approved program to repurchase its own common shares on the Tokyo Stock Exchange. The initiative reflects an active capital management strategy that may influence share liquidity and shareholder value in the near...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026